Showing results (1841-1850 of 2,138) with videos related to
Sort By:
Pageof 214
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/<i>KMT2A</i>Marius Bill, Krzysztof Mrózek, Jessica Kohlschmidt, et al.Microorganisms|August 28, 2020
Structural Insight into CVB3-VLP Non-Adjuvanted VaccineMinna M Hankaniemi, Mo A Baikoghli, Virginia M Stone, et al.Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.Human Molecular Genetics|November 2, 2001
Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophyS Biswas, F L Munier, J Yardley, et al.American Journal of Human Genetics|April 20, 2010
Discovery and functional analysis of a retinitis pigmentosa gene, C2ORF71Darryl Y Nishimura, Lisa M Baye, Rahat Perveen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3Thomas Fischer, Richard M Stone, Daniel J Deangelo, et al.Annals of the Rheumatic Diseases|February 9, 2006
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitisT Pham, R Landewé, S van der Linden, et al.Blood|December 28, 2007
A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemiaMitch Raponi, Jeffrey E Lancet, Hongtao Fan, et al.Journal of Medical Virology|September 19, 2022
Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapyRuthMabel Boytz, Mikołaj Słabicki, Sita Ramaswamy, et al.Human Mutation|January 13, 2015
Heterozygous triplication of upstream regulatory sequences leads to dysregulation of matrix metalloproteinase 19 in patients with cavitary optic disc anomalyRalph J Hazlewood, Benjamin R Roos, Frances Solivan-Timpe, et al.Pageof 214